Triglyceridspeicherkrankheiten sind autosomal rezessive Erkrankungen die durch Triglyceridansammlung und Myopathie oder Ichtiose gekennzeichnet sind. Auch Veränderungen der Serumlipide werden beobachtet.
1. |
Lefèvre C et al. (2001) Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. |
2. |
Fischer J et al. (2007) The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. |
3. |
Akiyama M et al. (2007) Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. |
4. |
Reilich P et al. (2011) The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. |
5. |
Lin P et al. (2012) Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy. |
6. |
Markesbery WR et al. (1974) Muscle carnitine deficiency. Association with lipid myopathy, vacuolar neuropathy, and vacuolated leukocytes. |
7. |
Rozenszajn L et al. (1966) Jordans' anomaly in white blood cells. Report of case. |
8. |
Angelini C et al. (1980) Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation. |
9. |
Fischer J et al. (2000) Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity. |
10. |
EI-Kabbany Z et al. (2003) Dorfman-Chanarin syndrome in Egypt. |
11. |
None (1953) The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB.). |
12. |
Huigen MC et al. (2015) Cerebral lipid accumulation in Chanarin-Dorfman Syndrome. |
13. |
Janssen MC et al. (2013) Symptomatic lipid storage in carriers for the PNPLA2 gene. |
14. |
OMIM.ORG article Omim 275630 |
15. |
Orphanet article Orphanet ID 165 |